Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FL094
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,000
Award facts
- Contract value 100% obligated
- $17,000.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a contract value of $17,000.38. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by February 2, 2026, and will be performed at the company's location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor, fulfills critical medical procurement needs for federal military and veteran healthcare systems through its extensive portfolio of pharmaceutical products. This delivery order for Biktarvy, an antiretroviral medication used in HIV treatment, exemplifies the company's role in supplying specialty medications across multiple therapeutic domains to the Defense Health Agency and other federal healthcare systems. The competitive award structure and firm fixed pricing demonstrate the company's capability to meet federal procurement requirements while maintaining cost efficiency in the government's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FL094?
SPE2DR26FL094 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FL094 worth?
The government has obligated $17,000 on SPE2DR26FL094.
Is contract SPE2DR26FL094 an order under another contract?
Yes. SPE2DR26FL094 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FL094 competed?
The extent of competition for SPE2DR26FL094 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award